Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Lordick

Showing results (21-30 of 366) with videos related to

Pageof 37
Sort By:
Best Practice & Research. Clinical Gastroenterology|May 12, 2021
Targeted and immunotherapy in the era of personalised gastric cancer treatmentSilvia Catanese, Florian Lordick
JAMA Oncology|March 30, 2018
Questions About a Clinical Trial Evaluating the Addition of Cetuximab to Definitive Chemoradiation Therapy With Paclitaxel and Cisplatin for Patients With Esophageal CancerAntoine Adenis, Florian Lordick
Current Opinion in Oncology|April 21, 2011
How will human epidermal growth factor receptor 2-neu data impact clinical management of gastric cancer?Sylvie Lorenzen, Florian Lordick
Deutsche Medizinische Wochenschrift (1946)|April 8, 2017
[Current Standard Diagnosis and Treatment of Colon Cancer]Florian Lordick, Joachim Mössner
Psychotherapie, Psychosomatik, Medizinische Psychologie|July 19, 2017
[Not Available]Anja Mehnert, Florian Lordick
Annals of Translational Medicine|January 25, 2021
Anti-PD1 monotherapy in hepatocellular carcinoma: a step forward or already behind?Silvia Catanese, Florian Lordick
Innovative Surgical Sciences|October 4, 2019
Chances, risks and limitations of neoadjuvant therapy in surgical oncologyFlorian Lordick, Ines Gockel
Best Practice & Research. Clinical Gastroenterology|September 21, 2016
Gastric cancer adjuvant therapyFlorian Lordick, Masanori Terashima
Hematology/Oncology Clinics of North America|May 15, 2017
Management of Metastatic Gastric CancerRadka Obermannová, Florian Lordick
Gastrointestinal Cancer Research : GCR|March 5, 2009
Current status and future of chemotherapy and biochemotherapy in gastroesophageal cancersFlorian Lordick, Dirk Jäger
Pageof 37

Showing results (21-30 of 366) with videos related to

Sort By:
Pageof 37
Best Practice & Research. Clinical Gastroenterology|May 12, 2021
Targeted and immunotherapy in the era of personalised gastric cancer treatmentSilvia Catanese, Florian Lordick
JAMA Oncology|March 30, 2018
Questions About a Clinical Trial Evaluating the Addition of Cetuximab to Definitive Chemoradiation Therapy With Paclitaxel and Cisplatin for Patients With Esophageal CancerAntoine Adenis, Florian Lordick
Current Opinion in Oncology|April 21, 2011
How will human epidermal growth factor receptor 2-neu data impact clinical management of gastric cancer?Sylvie Lorenzen, Florian Lordick
Deutsche Medizinische Wochenschrift (1946)|April 8, 2017
[Current Standard Diagnosis and Treatment of Colon Cancer]Florian Lordick, Joachim Mössner
Psychotherapie, Psychosomatik, Medizinische Psychologie|July 19, 2017
[Not Available]Anja Mehnert, Florian Lordick
Annals of Translational Medicine|January 25, 2021
Anti-PD1 monotherapy in hepatocellular carcinoma: a step forward or already behind?Silvia Catanese, Florian Lordick
Innovative Surgical Sciences|October 4, 2019
Chances, risks and limitations of neoadjuvant therapy in surgical oncologyFlorian Lordick, Ines Gockel
Best Practice & Research. Clinical Gastroenterology|September 21, 2016
Gastric cancer adjuvant therapyFlorian Lordick, Masanori Terashima
Hematology/Oncology Clinics of North America|May 15, 2017
Management of Metastatic Gastric CancerRadka Obermannová, Florian Lordick
Gastrointestinal Cancer Research : GCR|March 5, 2009
Current status and future of chemotherapy and biochemotherapy in gastroesophageal cancersFlorian Lordick, Dirk Jäger
Pageof 37